Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michail Mavros

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreatic Neoplasms
6
2021
234
2.540
 Why?
Postoperative Complications
13
2022
1033
1.560
 Why?
Venous Thromboembolism
2
2023
75
1.550
 Why?
Anti-Bacterial Agents
8
2019
820
1.500
 Why?
Intraoperative Complications
6
2017
125
1.400
 Why?
Surgical Procedures, Operative
4
2015
78
1.390
 Why?
Liver Neoplasms
7
2014
352
1.340
 Why?
Adenocarcinoma
4
2020
428
1.330
 Why?
Quality Improvement
5
2022
245
1.200
 Why?
Pancreaticoduodenectomy
2
2022
13
1.070
 Why?
Pancreatectomy
4
2021
18
1.000
 Why?
Digestive System Surgical Procedures
2
2014
35
0.970
 Why?
Hepatectomy
7
2020
33
0.910
 Why?
Fever
3
2013
129
0.840
 Why?
Surgical Wound Infection
2
2013
126
0.810
 Why?
Humans
57
2023
54284
0.770
 Why?
Symptom Assessment
1
2020
38
0.760
 Why?
Abdomen
3
2017
83
0.750
 Why?
Terminally Ill
1
2019
16
0.700
 Why?
Middle Aged
22
2023
13088
0.690
 Why?
Intraabdominal Infections
1
2019
10
0.690
 Why?
beta-Lactams
1
2019
29
0.680
 Why?
Fluoroquinolones
1
2019
37
0.670
 Why?
Benchmarking
3
2017
73
0.670
 Why?
Melanoma
1
2022
313
0.660
 Why?
Risk Adjustment
2
2015
27
0.650
 Why?
Tissue Adhesions
2
2015
7
0.640
 Why?
Gram-Positive Bacterial Infections
3
2012
36
0.620
 Why?
Blood Transfusion
2
2015
138
0.610
 Why?
Risk Factors
9
2023
3935
0.610
 Why?
Aminoglycosides
3
2012
22
0.600
 Why?
Retrospective Studies
13
2023
6432
0.600
 Why?
Referral and Consultation
1
2019
307
0.590
 Why?
Morbidity
5
2022
149
0.570
 Why?
Skin Neoplasms
1
2022
532
0.560
 Why?
Male
27
2023
27334
0.560
 Why?
Carcinoma, Hepatocellular
3
2014
203
0.560
 Why?
Bibliometrics
2
2013
24
0.550
 Why?
Colorectal Neoplasms
3
2014
236
0.540
 Why?
Patient Acceptance of Health Care
1
2019
333
0.540
 Why?
Spinal Injuries
1
2015
21
0.530
 Why?
Cervical Vertebrae
1
2015
65
0.530
 Why?
Economic Recession
2
2012
8
0.520
 Why?
Perioperative Care
1
2015
42
0.520
 Why?
Vancomycin
2
2012
88
0.520
 Why?
Female
28
2023
28441
0.510
 Why?
Aged
18
2020
10054
0.510
 Why?
Anti-Infective Agents
2
2013
110
0.510
 Why?
Gram-Negative Bacterial Infections
2
2012
42
0.510
 Why?
Multivariate Analysis
7
2017
643
0.510
 Why?
Bile Ducts, Intrahepatic
1
2014
17
0.500
 Why?
Iatrogenic Disease
1
2014
24
0.490
 Why?
Cholangiocarcinoma
1
2014
30
0.490
 Why?
Bile Duct Neoplasms
1
2014
33
0.490
 Why?
Prognosis
9
2022
2118
0.490
 Why?
Gentamicins
2
2012
36
0.460
 Why?
Biostatistics
1
2013
6
0.460
 Why?
Journal Impact Factor
1
2013
10
0.450
 Why?
Skin Diseases, Bacterial
1
2013
14
0.450
 Why?
Neoplasms
1
2023
1316
0.440
 Why?
Sternotomy
1
2012
9
0.440
 Why?
Surgical Sponges
1
2012
7
0.440
 Why?
Rectal Neoplasms
1
2013
51
0.440
 Why?
Antibiotic Prophylaxis
1
2013
67
0.430
 Why?
Publishing
1
2013
45
0.430
 Why?
Terminology as Topic
1
2013
72
0.430
 Why?
Treatment Outcome
11
2020
5604
0.430
 Why?
Survival Rate
8
2016
951
0.430
 Why?
Neoplasm Recurrence, Local
5
2014
644
0.420
 Why?
Research Personnel
1
2013
69
0.420
 Why?
Hernia, Abdominal
1
2011
6
0.420
 Why?
Surgical Mesh
1
2011
18
0.410
 Why?
Herniorrhaphy
1
2011
26
0.410
 Why?
Colitis
1
2012
52
0.410
 Why?
Comprehension
1
2013
115
0.400
 Why?
Pulmonary Atelectasis
1
2011
12
0.400
 Why?
Clostridium Infections
1
2012
62
0.400
 Why?
Colonic Neoplasms
1
2013
164
0.390
 Why?
Collagen
1
2012
223
0.390
 Why?
Influenza A Virus, H1N1 Subtype
1
2010
33
0.380
 Why?
Influenza Vaccines
1
2010
42
0.370
 Why?
Neutropenia
1
2010
120
0.370
 Why?
Tomography, X-Ray Computed
1
2015
1213
0.360
 Why?
Adaptation, Psychological
1
2011
244
0.350
 Why?
Wound Healing
1
2011
228
0.350
 Why?
Randomized Controlled Trials as Topic
5
2019
596
0.350
 Why?
Health Knowledge, Attitudes, Practice
2
2012
543
0.350
 Why?
Staphylococcal Infections
1
2012
300
0.340
 Why?
Biomedical Research
1
2012
240
0.340
 Why?
Influenza, Human
1
2010
120
0.340
 Why?
Stress, Psychological
1
2011
270
0.340
 Why?
Anticoagulants
2
2023
270
0.340
 Why?
Cardiac Surgical Procedures
1
2012
318
0.330
 Why?
Registries
2
2022
553
0.330
 Why?
Staphylococcus aureus
1
2012
361
0.330
 Why?
Lymphatic Metastasis
3
2022
256
0.330
 Why?
Attitude of Health Personnel
1
2012
397
0.320
 Why?
Vaccination
1
2010
294
0.320
 Why?
Students, Medical
1
2010
173
0.320
 Why?
Chemotherapy, Adjuvant
2
2021
119
0.300
 Why?
Greece
5
2012
19
0.290
 Why?
Survival Analysis
3
2019
735
0.270
 Why?
Aged, 80 and over
6
2020
3431
0.270
 Why?
Combined Modality Therapy
3
2019
692
0.270
 Why?
United States
6
2022
5217
0.260
 Why?
Neoplasm Staging
4
2015
806
0.260
 Why?
Severity of Illness Index
2
2020
1084
0.240
 Why?
Hospital Mortality
2
2017
465
0.240
 Why?
Adult
12
2019
14207
0.230
 Why?
Asia
2
2013
32
0.220
 Why?
Ontario
2
2019
50
0.220
 Why?
Colectomy
1
2022
33
0.220
 Why?
Aftercare
1
2023
81
0.220
 Why?
North America
2
2013
68
0.220
 Why?
Pancreas
1
2022
80
0.220
 Why?
Europe
2
2013
102
0.220
 Why?
Databases, Factual
5
2017
684
0.220
 Why?
Risk Assessment
4
2015
1361
0.210
 Why?
Hemorrhage
1
2023
208
0.200
 Why?
Leucovorin
1
2021
18
0.200
 Why?
Sentinel Lymph Node Biopsy
1
2022
127
0.200
 Why?
Fluorouracil
1
2021
61
0.200
 Why?
Bacterial Infections
2
2012
105
0.190
 Why?
International Normalized Ratio
1
2020
29
0.190
 Why?
Artificial Intelligence
1
2021
85
0.190
 Why?
Patient Discharge
1
2023
353
0.190
 Why?
Nausea
1
2020
52
0.190
 Why?
Neoadjuvant Therapy
1
2021
125
0.190
 Why?
Mortality
2
2012
102
0.180
 Why?
Antineoplastic Agents
2
2021
1300
0.180
 Why?
Fatigue
1
2020
129
0.180
 Why?
Liver Transplantation
1
2021
160
0.180
 Why?
Hospice Care
1
2019
27
0.170
 Why?
Medical Oncology
1
2020
102
0.170
 Why?
Follow-Up Studies
5
2015
2387
0.160
 Why?
Population Surveillance
1
2019
183
0.160
 Why?
Logistic Models
3
2015
995
0.150
 Why?
Drug Therapy, Combination
1
2019
426
0.150
 Why?
Microbial Sensitivity Tests
3
2012
290
0.150
 Why?
Pain
1
2020
405
0.150
 Why?
Appendiceal Neoplasms
1
2016
10
0.140
 Why?
Adenocarcinoma, Mucinous
1
2016
23
0.140
 Why?
Length of Stay
2
2017
683
0.140
 Why?
Glasgow Coma Scale
1
2015
48
0.140
 Why?
Blood Grouping and Crossmatching
1
2015
6
0.140
 Why?
Disease-Free Survival
2
2016
485
0.140
 Why?
Fees and Charges
1
2015
7
0.130
 Why?
Peritoneal Neoplasms
1
2016
60
0.130
 Why?
Depression
1
2020
595
0.130
 Why?
Proportional Hazards Models
2
2016
431
0.130
 Why?
Hyperthermia, Induced
1
2016
107
0.130
 Why?
Time Factors
4
2016
3213
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1056
0.130
 Why?
Chi-Square Distribution
2
2012
318
0.130
 Why?
Peritoneum
1
2014
12
0.130
 Why?
Neoplasms, Multiple Primary
1
2014
45
0.120
 Why?
Preoperative Care
2
2015
184
0.120
 Why?
Gastrectomy
1
2014
64
0.120
 Why?
Occupational Diseases
1
2014
93
0.120
 Why?
Odds Ratio
2
2012
604
0.120
 Why?
Air Conditioning
1
2013
1
0.120
 Why?
SEER Program
1
2013
91
0.120
 Why?
Authorship
1
2013
14
0.110
 Why?
Meta-Analysis as Topic
1
2013
39
0.110
 Why?
Young Adult
3
2019
4318
0.110
 Why?
Fibromatosis, Abdominal
1
2012
2
0.110
 Why?
Fibromatosis, Aggressive
1
2012
5
0.110
 Why?
Radiation Injuries
1
2014
153
0.110
 Why?
Phenazopyridine
1
2012
4
0.110
 Why?
Carcinoembryonic Antigen
1
2012
15
0.110
 Why?
Abdominal Neoplasms
1
2012
19
0.110
 Why?
Cystitis
1
2012
18
0.110
 Why?
Gram-Negative Bacteria
1
2012
37
0.110
 Why?
Pelvic Neoplasms
1
2012
20
0.110
 Why?
Nonprescription Drugs
1
2012
42
0.110
 Why?
Enterobacteriaceae
1
2012
11
0.110
 Why?
Research
1
2013
110
0.110
 Why?
Hepatitis B Vaccines
1
2012
5
0.110
 Why?
Caregivers
1
2014
241
0.110
 Why?
Pneumococcal Vaccines
1
2012
10
0.110
 Why?
Comorbidity
1
2014
663
0.110
 Why?
Meningococcal Vaccines
1
2012
13
0.100
 Why?
Hot Temperature
1
2013
199
0.100
 Why?
Periodicals as Topic
1
2013
65
0.100
 Why?
Surgical Tape
1
2011
2
0.100
 Why?
House Calls
1
2012
25
0.100
 Why?
Wound Closure Techniques
1
2011
5
0.100
 Why?
Hepatitis B
1
2012
27
0.100
 Why?
Equipment Design
1
2013
318
0.100
 Why?
Tissue Adhesives
1
2011
15
0.100
 Why?
Analgesics
1
2012
106
0.100
 Why?
Liver Cirrhosis
1
2014
216
0.100
 Why?
Evidence-Based Medicine
1
2012
281
0.100
 Why?
Pregnancy Complications, Infectious
1
2012
75
0.100
 Why?
Postoperative Care
1
2011
121
0.090
 Why?
Epstein-Barr Virus Infections
1
2010
34
0.090
 Why?
Internet
1
2013
275
0.090
 Why?
Drug Administration Schedule
1
2010
401
0.090
 Why?
Developed Countries
1
2009
12
0.090
 Why?
Developing Countries
1
2009
53
0.090
 Why?
Social Support
1
2011
299
0.090
 Why?
Antiviral Agents
1
2010
188
0.080
 Why?
Physicians
1
2012
247
0.080
 Why?
Magnetic Resonance Imaging
1
2015
1604
0.080
 Why?
Cohort Studies
1
2012
1543
0.080
 Why?
Intraoperative Care
2
2017
57
0.070
 Why?
Lung Neoplasms
1
2012
642
0.070
 Why?
Statistics, Nonparametric
2
2015
232
0.070
 Why?
Analysis of Variance
2
2017
635
0.060
 Why?
Hospitalization
3
2015
705
0.060
 Why?
Prospective Studies
3
2019
2604
0.060
 Why?
Bayes Theorem
1
2021
123
0.050
 Why?
Tissue Donors
1
2021
110
0.050
 Why?
Age Factors
2
2013
1198
0.040
 Why?
Operating Rooms
1
2017
40
0.040
 Why?
Propensity Score
1
2017
137
0.040
 Why?
Emergency Treatment
1
2015
32
0.030
 Why?
Neoplasm, Residual
1
2016
166
0.030
 Why?
Blood Loss, Surgical
1
2015
79
0.030
 Why?
Scattering, Radiation
1
2014
31
0.030
 Why?
Hospital Costs
1
2015
84
0.030
 Why?
Kaplan-Meier Estimate
1
2016
514
0.030
 Why?
Radiation Protection
1
2014
55
0.030
 Why?
Liver Failure
1
2014
27
0.030
 Why?
Radiation Dosage
1
2014
170
0.030
 Why?
Survival
1
2013
16
0.030
 Why?
Electrosurgery
1
2012
10
0.030
 Why?
Surgery Department, Hospital
1
2012
6
0.030
 Why?
Methenamine
1
2012
2
0.030
 Why?
Drug Labeling
1
2012
12
0.030
 Why?
Urinary Tract
1
2012
26
0.030
 Why?
Hippurates
1
2012
10
0.030
 Why?
Consumer Health Information
1
2012
21
0.030
 Why?
Drug Resistance, Multiple, Bacterial
1
2012
60
0.030
 Why?
Meningococcal Infections
1
2012
7
0.030
 Why?
Pneumococcal Infections
1
2012
11
0.030
 Why?
Patient Selection
1
2014
286
0.030
 Why?
Emergencies
1
2012
92
0.030
 Why?
Adolescent
2
2014
6897
0.020
 Why?
Acute Disease
1
2012
403
0.020
 Why?
Cost of Illness
1
2012
133
0.020
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2012
142
0.020
 Why?
Acyclovir
1
2010
10
0.020
 Why?
Escherichia coli
1
2012
250
0.020
 Why?
Child
2
2014
7341
0.020
 Why?
Research Design
1
2012
374
0.020
 Why?
Clinical Trials as Topic
1
2012
490
0.020
 Why?
Health Status
1
2012
368
0.020
 Why?
Prevalence
1
2012
1025
0.020
 Why?
Cause of Death
1
2009
165
0.020
 Why?
Aging
1
2013
784
0.020
 Why?
Liver
1
2012
1225
0.020
 Why?
Pregnancy
1
2012
2620
0.020
 Why?
Infant
1
2012
3817
0.010
 Why?
Child, Preschool
1
2012
4147
0.010
 Why?
Animals
1
2011
14385
0.010
 Why?
Mavros's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (7) people
_
Similar People Expand Description
See all (25) people
_
Same Department Expand Description
Search Department